Head of Research & Technology · SANGAMO THERAPEUTICS, INC · Common Stock
Side
F
Value
$393
Shares
832
Price
$0.47
Executed
Feb 24, 2026
Disclosed
Feb 26, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Feb 24 executedFeb 26, 2026 disclosed
SGMO · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+1 / 25
$393 reported value · 0.4% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Davis Gregory D filed this Form 4 reporting a tax withholding of SGMO on Feb 24, 2026. It became public on Feb 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Head of Research & Technology
Davis Gregory Dcik:0002041855
Issuer
SANGAMO THERAPEUTICS, INCcik:0001001233
Revision history · 0
No field has changed since this record was first ingested.
Company events
No records
No material filings recorded for this issuer.
Source error
Price history for SGMO is unavailable.
An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.
